Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A1 | P22736 | 1/20 | 0.51 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ITGA1 | P56199 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7782795 | 0.89 | AKR1C3 (0.47) | NR4A1KMT2AMAPTTDP1ITGA1 | |
| Ammonia Solution, Strong SCHEMBL11460421 | 0.85 | NR4A1 (0.57) | NR4A1SRD5A2MAPK1KMT2AMEN1 | |
| SCHEMBL11022413 | 0.78 | TSHR (0.57) | TDP1ALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL10586122 | 0.78 | ALDH1A1 (0.39) | KMT2AMEN1TDP1ALDH1A1CYP1A2 | |
| SCHEMBL7792236 | 0.77 | CNR2 (0.51) | NR4A1SRD5A2MAPK1KMT2AMEN1 | |
| SCHEMBL9822535 | 0.77 | NR4A1 (0.59) | NR4A1SRD5A2MAPK1KMT2AMEN1 | |
| SCHEMBL5412003 | 0.76 | MEN1 (0.40) | KMT2AMEN1MAPTALDH1A1CYP1A2 | |
| SCHEMBL9809151 | 0.76 | NR4A1 (0.58) | NR4A1SRD5A2MAPK1KMT2AMEN1 | |
| SCHEMBL18762902 | 0.75 | CA1 (0.38) | KMT2AMEN1CYP1A2L3MBTL1CES2 | |
| SCHEMBL7585613 | 0.75 | NR4A1 (0.56) | NR4A1SRD5A2MAPK1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3395323-B1 | METHOD FOR TREATING HAIR | KAO CORP (JP) | 2021-09-29 | — | — | EP | disclosed |
| US-20190038532-A1 | METHOD FOR TREATING HAIR | KAO CORPORATION (JP) | 2019-02-07 | — | — | US | disclosed |
| EP-3395323-A1 | HAIR TREATMENT METHOD | Kao Corporation (JP) | 2018-10-31 | — | — | EP | disclosed |
| EP-0672405-B1 | Hair treatment composition | KAO CORP (JP) | 2001-11-14 | — | — | EP | disclosed |
| EP-0662314-B1 | Method of hair treatment | KAO CORP (JP) | 1999-11-03 | — | — | EP | disclosed |
| EP-0529437-B1 | Hair treatment composition | KAO CORP (JP) | 1996-07-17 | — | — | EP | disclosed |
| EP-0672405-A1 | Hair treatment composition | KAO CORPORATION (JP) | 1995-09-20 | — | — | EP | disclosed |
| EP-0662314-A1 | Method of hair treatment | Kao Corporation (JP) | 1995-07-12 | — | — | EP | disclosed |
| EP-0529437-A1 | Hair treatment composition | Kao Corporation (JP) | 1993-03-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190038532-A1 | METHOD FOR TREATING HAIR | TYR, POLR1C, CA7 | NR4A1 3501/4885SRD5A2 89/4885MAPK1 2632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.